BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30

• Press Releases

  Aldeyra Therapeutics to Host Regulatory Update Webcast

  September 28, 2026

   · 

  1 min read
• Press Releases

  AngioDynamics to Report Fiscal 2027 First Quarter Results on October 8, 2026

  September 28, 2026

   · 

  1 min read
• Press Releases

  PreveCeutical Announces Non-Brokered Private Placement

  September 28, 2026

   · 

  4 min read
• Press Releases

  Defence Therapeutics Provides Corporate Update as Company Executes on Strategic Priorities

  September 28, 2026

   · 

  5 min read
• Press Releases

  Eccogene Receives $50 Million Milestone Payment from AstraZeneca Following Initiation of Global Phase 3 Program for Elecoglipron (AZD5004/ECC5004)

  September 28, 2026

   · 

  4 min read
• Press Releases

  Egetis Therapeutics Announces U.S. FDA Approval of EMCITATE® (tiratricol) for Patients with MCT8 Deficiency

  September 28, 2026

   · 

  11 min read
• Press Releases

  AstraZeneca Makes $2 Billion Strategic Equity Investment in Summit Therapeutics

  September 28, 2026

   · 

  17 min read
• Press Releases

  TempraMed Announces Upsize to Offering

  September 28, 2026

   · 

  6 min read
• Press Releases

  Currus Biologics announces FDA IND clearance for Phase 1 trial of CUR-001 in mesothelin-positive advanced refractory solid tumours

  September 28, 2026

   · 

  4 min read
• Press Releases

  Medicure Announces Completion of Enrollment in Its MEND-PNPO Phase 3 Clinical Trial

  September 28, 2026

   · 

  7 min read